Loopbaan van Andrew Keck
Eerdere bekende functies van Andrew Keck
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TYME TECHNOLOGIES, INC. | Comptroller/Controller/Auditor | 22-11-2011 | 26-04-2013 |
| Directeur/Bestuurslid | 22-11-2011 | 26-04-2013 | |
| Algemeen Directeur | 22-11-2011 | 26-04-2013 | |
| Financieel Directeur/CFO | 22-11-2011 | 26-04-2013 | |
| Oprichter | 22-11-2011 | 26-04-2013 | |
| President | 22-11-2011 | 26-04-2013 | |
| Bedrijfssecretaris | 22-11-2011 | 26-04-2013 | |
| Treasurer | 22-11-2011 | 26-04-2013 |
Statistieken
Internationaal
| Verenigde Staten | 2 |
Operationeel
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoraal
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
- Beurs
- Insiders
- Andrew Keck
- Ervaring
